| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41f348171d4db3451c79fee043df6cc0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ace46170a1b4905c5ad2dddcb7ac3db |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C327-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-60 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
2015-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0c908afb122ffd66953b2fcead60bd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bbcd84d01ae513d9e0da9108683b704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68afc804f43993cbbb8aab73d7be1a58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbc40d9727160f96be9b12ced62e6838 |
| publicationDate |
2015-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015175559-A1 |
| titleOfInvention |
Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings |
| abstract |
The present invention discloses cysteine prodrugs having the general formula: n n n n n n n n n n cystine dimmers of the cysteine prodrugs having the general formula: n n n n n n n n n n protected cysteine analogs having the general formula: n n n n n n n n n n and dimmers of the protected cysteine analogs having the general formula: n n n n n n n n n n The invention further encompasses pharmaceutical compositions containing the disclosed prodrugs, dimmers, analogs, and methods of using such compounds for treatment of schizophrenia and drug addiction. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018145109-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10961187-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10786471-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10112897-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9630937-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10358414-B2 |
| priorityDate |
2008-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |